134 related articles for article (PubMed ID: 18632808)
1. Biodistribution and radiation dosimetry of 99mTc-HMPAO-labeled monocytes in patients with rheumatoid arthritis.
Bennink RJ; Thurlings RM; van Hemert FJ; Voermans C; Dohmen SE; van Eck-Smit BL; Tak PP; Busemann-Sokole E
J Nucl Med; 2008 Aug; 49(8):1380-5. PubMed ID: 18632808
[TBL] [Abstract][Full Text] [Related]
2. Labeling of autologous monocytes with 99mTc-HMPAO at very high specific radioactivity.
van Hemert FJ; Thurlings R; Dohmen SE; Voermans C; Tak PP; van Eck-Smit BL; Bennink RJ
Nucl Med Biol; 2007 Nov; 34(8):933-8. PubMed ID: 17998095
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and radiation dosimetry of stabilized 99mTc-exametazine-labeled leukocytes in normal subjects.
Robins PD; Salazar I; Forstrom LA; Mullan BP; Hung JC
J Nucl Med; 2000 May; 41(5):934-40. PubMed ID: 10809211
[TBL] [Abstract][Full Text] [Related]
4. Intraindividual comparison of 99mTc-labelled anti-SSEA-1 antigranulocyte antibody and 99mTc-HMPAO labelled white blood cells for the imaging of infection.
Gratz S; Behr T; Herrmann A; Dresing K; Tarditi L; Franceschini R; Rhodes B; Stürmer KM; Becker W
Eur J Nucl Med; 1998 Apr; 25(4):386-93. PubMed ID: 9553168
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 99mTc-RP128 as a potential inflammation imaging agent: human dosimetry and first clinical results.
Caveliers V; Goodbody AE; Tran LL; Peers SH; Thornback JR; Bossuyt A
J Nucl Med; 2001 Jan; 42(1):154-61. PubMed ID: 11197967
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection.
Gratz S; Rennen HJ; Boerman OC; Oyen WJ; Mast P; Behr TM; Corstens FH
J Nucl Med; 2002 Jul; 43(7):918-24. PubMed ID: 12097463
[TBL] [Abstract][Full Text] [Related]
7. An in vitro study to compare 99mTc-stannous colloids and 99mTc-HMPAO for labelling human leukocytes.
Capriotti G; D'Alessandria C; Garin E; Weber E; Devillers A; Lehmann K; Corsetti F; Lecloirec J; Meller J; Becker W; Moisan A; Signore A
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):229-36. PubMed ID: 15499297
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m-labeled anti-EGF-receptor antibody in patients with tumor of epithelial origin: I. Biodistribution and dosimetry for radioimmunotherapy.
Iznaga-Escobar N; Torres LA; Morales A; Ramos M; Alvarez I; Pérez N; Fraxedas R; Rodríguez O; Rodríguez N; Pérez R; Lage A; Stabin MG
J Nucl Med; 1998 Jan; 39(1):15-23. PubMed ID: 9443731
[TBL] [Abstract][Full Text] [Related]
9. Targeting monocytes and macrophages by means of SPECT and PET.
Van De Wiele C; Sathekge M; Maes A
Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):269-75. PubMed ID: 24844256
[TBL] [Abstract][Full Text] [Related]
10. Placental binding and transfer of radiopharmaceuticals: technetium-99m d, 1-HMPAO.
Owunwanne A; Omu A; Patel M; Mathew M; Ayesha A; Gopinath S
J Nucl Med; 1998 Oct; 39(10):1810-3. PubMed ID: 9776293
[TBL] [Abstract][Full Text] [Related]
11. The radiation dosimetry and normal value study of 99mTc-HMPAO-labeled leukocytes.
Brown ML; Hung JC; Vetter RJ; O'Connor MK; Chowdhury S; Forstrom LA
Invest Radiol; 1994 Apr; 29(4):443-7. PubMed ID: 8034450
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution and dosimetry of (99m)Tc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies.
Van de Wiele C; Dumont F; Dierckx RA; Peers SH; Thornback JR; Slegers G; Thierens H
J Nucl Med; 2001 Nov; 42(11):1722-7. PubMed ID: 11696645
[TBL] [Abstract][Full Text] [Related]
13. Biodistribution and dosimetry of 99mTc-BTAP-annexin-V in humans.
Kemerink GJ; Boersma HH; Thimister PW; Hofstra L; Liem IH; Pakbiers MT; Janssen D; Reutelingsperger CP; Heidendal GA
Eur J Nucl Med; 2001 Sep; 28(9):1373-8. PubMed ID: 11585297
[TBL] [Abstract][Full Text] [Related]
14. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
[TBL] [Abstract][Full Text] [Related]
15. [Biodistribution of 99mTC-HMPAO in healthy rats and B16 melanoma carriers].
Calderón CF; Collazo A; Cepero W; Rodríguez JC; Montalvo M; Robustillo M; Avila A; Pérez RM
Rev Esp Med Nucl; 1999 Dec; 18(6):425-30. PubMed ID: 10611568
[TBL] [Abstract][Full Text] [Related]
16. Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women.
Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Pichardo-Romero PA
Nucl Med Commun; 2008 Aug; 29(8):741-7. PubMed ID: 18753829
[TBL] [Abstract][Full Text] [Related]
17. 111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content.
Blocklet D; Toungouz M; Kiss R; Lambermont M; Velu T; Duriau D; Goldman M; Goldman S
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):440-7. PubMed ID: 12722741
[TBL] [Abstract][Full Text] [Related]
18. In vitro assessment of cytotoxicity and labeling efficiency of 99mTc-HMPAO with stromal vascular fraction of adipose tissue.
Verma VK; Beevi SS; Tabassum A; Kumaresan K; Kamaraju RS; Arbab AS; Chelluri LK
Nucl Med Biol; 2014 Oct; 41(9):744-8. PubMed ID: 25037755
[TBL] [Abstract][Full Text] [Related]
19. Radiation dosimetry of a 99mTc-labeled IgM murine antibody to CD15 antigens on human granulocytes.
Mozley PD; Stubbs JB; Dresel SH; Barraclough ED; Smith T; Patel M; Finkelman C; Sparks RB; Thakur ML; Mathur A; Alavi A
J Nucl Med; 1999 Apr; 40(4):625-30. PubMed ID: 10210221
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of early treatment response and predicting the need for colectomy in active ulcerative colitis with 99mTc-HMPAO white blood cell scintigraphy.
Bennink RJ; Peeters M; Rutgeerts P; Mortelmans L
J Nucl Med; 2004 Oct; 45(10):1698-704. PubMed ID: 15471836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
